Doctors Can't Spot Key Genetic Mutations in Common Ovarian Tumors by Sight Alone

A new study shows that pathologists cannot reliably identify FOXL2 mutations in sex cord-stromal ovarian tumors based on microscopic appearance alone. The finding has immediate implications for diagnostic accuracy and treatment selection, potentially requiring genetic testing as standard practice rather than optional follow-up.

Originaltitel: FOXL2 Mutation Status in Sex Cord-stromal Tumors Cannot be Predicted by Morphology